Fibrin Sealants Market Report,

Fibrin sealant is mainly composed of a mixture of concentrated fibrinogen and thrombin that creates a fibrin matrix that is slowly degraded by the body's fibrinolytic system. It is currently used in the clinical arena for many applications. Fibrin sealant is also called fibrin glue is used as a surgical formulation to create a fibrin clot for haemostasis or wound healing. The utilization of fibrin sealants to augment haemostasis, seal tissues, and facilitate targeted delivery of drugs is increasing globally. TISSEEL as the first commercial fibrin sealant was approved by FDA on first of May 1998. These FDA-approved fibrin sealants contain human fibrinogen and human thrombin.

Fibrin Sealants Market Outlook

The global market is estimated and forecasted in terms of revenue (USD million) generated by the fibrin sealants market. The fibrin sealants market has shown sustainable growth owing to increasing prevalence of chronic diseases and rise in number of surgical procedures globally. Moreover, growing health concern coupled with rise in geriatric population are the prominent factors leading to the growth of fibrin sealants market globally. Rising demand for fibrin sealant patches globally is expected to support the market of fibrin sealants across the globe. However, stringent government policies and FDA clearance of products are factors which are hindering the growth of this market.

Fibrin Sealants Market Segmental Overview

The report analyses the fibrin sealants market on the basis of type, end user, application and geography. 

Fibrin Sealants Market by Type 

Based on type, the market is segmented into patches, liquid, gel and powder. The fibrin sealant is commercially available in various forms such as patches, liquid, gel and powdered. Surgical bleeding is a common occurrence and varies widely in presentation and consequences across surgery types. Surgical bleeding can range from mild or moderate in intensity to uncontrolled or traumatic. Some bleeding scenarios may be straightforward to manage; however, bleeding can also become more problematic, depending on several factors, including bleeding intensity, anatomic location, visibility and accessibility of bleeding source, and coagulation status. Depending on the type of surgery the type of the fibrin sealant is decided by the surgeons. 

Fibrin Sealants Market by End User 

Furthermore, based on end user the global fibrin sealants market is categorised into hospitals, ambulatory surgical centres and clinic. Fibrin sealants are mostly demand in the hospitals as many major and critical surgeries such as cardio vascular, neurological surgeries are done in the hospitals. The ambulatory surgical centres are gaining popularity in developed countries which provides a developing potential to the growth of the fibrin sealant market. 

Fibrin Sealants Market by Application 

Based on application, this fibrin sealants market is classified into cardiac surgery, vascular surgeries, orthopaedic surgeries, neurosurgery, general surgery and others. Others includes dental surgery, plastic and reconstructive surgery, thoracic surgery, etc. Currently, fibrin sealant is used in virtually every surgical specialty. The primary area of fibrin sealant is cardiovascular surgery, where applications include sealing of complex suture lines, vascular conduits, cannulation sites, and vascular anastomoses Fibrin sealant has been used in cardiovascular surgery in conjunction with polytetrafluoroethylene patches, polytetrafluoroethylene bypass grafts, woven dacron grafts and pericardial patches. In pulmonary thoracic surgery, fibrin sealant helps to seal air leaks and close bronchopleural fistulas as well as reinforce suture or staple lines after thoracotomy or lung resection. Likewise, in neurosurgery, fibrin sealant has commonly been used as an adjunct to Dural closures, to reduce postoperative cerebral spinal fluid leakage and in the repair of Dural defects. Additional applications include microvascular decompression, laminectomy, tumour resection via craniotomy, myelomeningocele repair, rhizotomy, and arteriovenous malformation repair. 

Fibrin Sealants Market by Geography 

Geographically, the global fibrin sealants market is categorized into North America, Europe, Asia Pacific and rest of the world. Rest of the world comprises of Latin America and Middle East & Africa. Currently, North America is the largest consumer of fibrin sealant globally due to well established healthcare infrastructure and large patient pool. Fibrin sealant became the first modern era material approved as a haemostat in the United States in 1998. It is the only agent presently approved as a haemostat, sealant, and adhesive by the Food and Drug Administration (FDA). The product is now supplied as patches in addition to the original liquid formulations. Moreover, Asia pacific is expected to witness the fastest growth during the forecast period. The growth in the region is mainly attributable to aging population, rising incidence of burns cases and increasing per capita income. Demand for fibrin glue products is also increasing due to rising number of burn cases and road accidents.

Fibrin Sealants Market Key Players

Key players of the global fibrin sealants market are Baxter, Johnson & Johnson Services, Inc, B. Braun Melsungen AG, Cardinal Health, CSL Behring, Asahi Kasei Medical Co., Ltd, LifeBond, Shanghai RAAS, C.R. Bard (Bard Medical, Davol), Sea Run, Tissuemed, Hualan Biological, Sanofi, The Medicines Company, etc. Presently, fibrin sealant is an emerging industry. The fibrin sealant market is dominated by few well establish players and other players includes regional players in various countries. New product launches and research & development are the major strategies adopted by the players to rei9nforce their position in the global market.